Fiche centre
Bradfordhill ( Site 0702)
Santiago — Chile
Essais liés2clinical trials
VilleSantiagolocalisation
PaysChilelocalisation
SourcelocaleCSV/MySQL
Informations
centreImport ClinicalTrials.gov
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MK-0472 | Parkinson | Phase 1 | NCT05853367 | Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) | ACTIVE_NOT_RECRUITING |
| Pembrolizumab | Parkinson | Phase 3 | NCT07216703 | A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) | RECRUITING |